## Abstract Basic fibroblast growth factor (bFGF) is produced by bone marrow stromal cells as well as by normal and leukemic hematopoietic cells. In this study, we examine the direct effects of bFGF on erythroid differentiation in K562 cells in order to determine whether bFGF can promote the expres
Restricted expression of an MHC alloantigen in cells of the erythroid series: A specific marker for erythroid differentiation
✍ Scribed by Longenecker, B. M. ;Mosmann, T. R.
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1980
- Tongue
- English
- Weight
- 342 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0091-7419
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The spectrum of reactivity with various types of cells of a monoclonal antibody (CH‐4) which detects a private MHC antigen of chickens was analysed. CH‐4 agglutinates only RBCs that possess the B^2^ (MHC) haplotype. A new rosetteforming cell (RFC) assay was devised to detect individual cells (excluding RBCs) that possess the CH‐4 specificity on their cell surfaces. RBCs that have CH‐4 chemically coupled to their surfaces attach to, and form rosettes with, B^2^ antigen‐bearing cells. Most non‐RBC RFC were detected in active erythropoietic organs (adult bone marrow and embryonic spleen), and none were found in organs where erythropoiesis does not occur: adult thymus and bursa. Preincubation of bone marrow cells with CH‐4 plus complement almost completely inhibits their capacity to form CFU‐E without affecting their ability to form GM‐CFU. In addition, CH‐4 plus complement does not inhibit the capacity of B^2^/B^2^ lymphocytes to induce a graft‐versus‐host reaction under conditions where anti‐B^2^ lymphocyte alloantisera are completely inhibitory. Our results strongly suggest that CH‐4 monoclonal antibodies detect a private specificity on a gene product of the B‐G locus whose expression is restricted to erythroid stem cells and erythrocytes.
📜 SIMILAR VOLUMES
In cancer patients, NK cell inhibitory receptors (IR) are expressed on a fraction of melanomaspecific lymphocytes with a unique reactivity for tumor antigens derived from normal, nonmutated genes (differentiation antigens). It is presently not known whether expression of these receptors is induced d